Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

Since target therapy with mTOR inhibitors plays an important role in the current management of clear cell renal cell carcinoma (RCC), there is an increasing demand for predictive biomarkers, which may help to select patients that are most likely to benefit from personalized treatment. When dealing w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Cancer Res
Главные авторы: Fiorini, Claudia, Massari, Francesco, Pedron, Serena, Sanavio, Sara, Ciccarese, Chiara, Porcaro, Antonio Benito, Artibani, Walter, Bertoldo, Francesco, Zampini, Claudia, Sava, Teodoro, Ficial, Miriam, Caliò, Anna, Chilosi, Marco, D’Amuri, Alessandro, Sanguedolce, Francesca, Tortora, Giampaolo, Scarpa, Aldo, Delahunt, Brett, Porta, Camillo, Martignoni, Guido, Brunelli, Matteo
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266722/
https://ncbi.nlm.nih.gov/pubmed/25520878
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы